Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Molecular Diagnostics
 More »

  • FDA Approves Roche EGFR Mutation CDx for NSCLC
    Health, in a statement. "Companion diagnostics play an important role in determining ... The U.S. Food and Drug Administration this week approved Roche Molecular Systems' cobas® ...
    5-15-2013
  • Highlights from AACR
    ... label-free kinetic measurements for molecular interaction analysis with high ... An agreement between Advanced Cell Diagnostics (ACD) and The Johns Hopkins University's ...
    5-15-2013
  • VC Investment: Not Quite Dead?
    financing was BiOptix Diagnostics, a Boulder, CO, company developing its E-SPR (enhanced surface plasmon resonance) technology platform for the detection of molecular interactions. ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. HTG Molecular Diagnostics and Sanofi Agreement announced March 30, 2012 Collaborative program to identify biomarkers that may lead to the development ...
    5-9-2013
  • Cancer Diagnostics, Pushing the Boundaries
    Commenting on the recent AACR meeting, analysts from Mizuho Securities observed that molecular diagnostics are "clearly an essential part of oncology," with "a lot of optimism ...
    5-8-2013
  • Analytik Jena Acquires Sepsis Test Among SIRS-Lab Assets
    Analytik Jena will expand into the market for sepsis diagnostics by acquiring all assets of the bankrupt company SIRS-Lab, a developer of molecular diagnostic methods and testing ...
    5-6-2013
  • Exposing the Exposome
    ... "These modifications act almost like a molecular switch, a DNA code above the one that is ... will undoubtedly also be embraced by diagnostics and pharmaceutics markets," says Dr. ...
    5-1-2013
  • Biomarkers Take Center Stage
    ... measured in the blood to be tied back to the molecular biology taking place in the tumor. ... be licensed to the end users to develop diagnostics that can be validated as time goes on. ...
    5-1-2013
  • Separation of Therapeutic Biomolecules
    ... Dr. Hearn's group employs molecular dynamics simulations to understand dehydration events ... The problem presented by Reinhard Braaz at Roche Diagnostics is the high back pressure ...
    5-1-2013
  • The Globalization of IVD Companies
    ... While the molecular diagnostics segment is forecast to grow at more than 12% annually, it will become a $9 billion industry in 2017 (compare that to immunochemistry's forecasted ...
    5-1-2013
  • Protein Proteolysis Mix
    Our products are also used to support molecular diagnostics and human identification. Trypsin/Lys-C mix is a combination of Trypsin Gold and rLys-C proteases. The mix increases ...
    5-1-2013
  • Qiagen Snaps Up Ingenuity for $105M
    of biological information is becoming a cornerstone of Qiagen's ecosystem of Sample & Assay Technologies for molecular testing-both in life sciences research and in diagnostics." ...
    4-30-2013
  • GEN | Biolinks
    ... Inc Novabiotics Ltd Novadigm Therapeutics, Inc Novartis Novartis Molecular Diagnostics Novasep Process Novavax, Inc Novici Biotech Novira Therapeutics, Inc Novozymes ...
  • Illumina Partnership Eyes Expanded Presence in China
    is enabling a dramatic improvement in both coverage and accuracy for molecular diagnostics, and we look forward to additional partnerships that continue to drive this ...
    4-18-2013
  • Stockholm-Uppsala Region Ups the Ante
    ... Landegren is Mats Nilsson, who was also a co-founder of Parallele, Olink, and Qlinea. Dr. Nilsson, a professor of molecular diagnostics at Uppsala University and a member of ...
    4-15-2013
  • More »

    Journal Articles

  • Treatment Options to Manage Wound Biofilm
    Curtis E. Jones, John P. Kennedy
    Advances in Wound Care
    Conclusion: Bioburden is a significant barrier to healing for all chronic wounds. Molecular diagnostics provide the first objective means of assessing wound bioburden. The accuracy ...
  • NDRG4 is Downregulated in Glioblastoma and Inhibits Cell Proliferation
    Wenchao Ding, Jing Zhang, Jae-Geun Yoon, Dongyan Shi, Gregory Foltz, Biaoyang Lin
    OMICS: A Journal of Integrative Biology
    These new observations can inform the selection of lead molecular compounds for drug discovery as well as novel diagnostics for GBM. They also lend evidence to NDRG4 a role of ...
  • A Structural Analysis of Glycosaminoglycans from Lethal and Nonlethal...
    Amanda Weyers, Bo Yang, Dae Sung Yoon, Jong-Hwan Park, Fuming Zhang, Kyung Bok Lee, Robert J. Linhardt
    OMICS: A Journal of Integrative Biology
    Truly innovative diagnostics that inform disease susceptibility, prognosis, and/or ... Molecular weight analysis showed that glycosaminoglycans from cancerous tissue had a ...
  • Challenges to Developing Proteomic-Based Breast Cancer Diagnostics
    Richard R. Drake, Lisa H. Cazares, E. Ellen Jones, Thomas W. Fuller, O. John Semmes, Christine Laronga
    OMICS: A Journal of Integrative Biology
    Challenges to Developing Proteomic-Based Breast Cancer Diagnostics OMICS: A Journal of ... There still remains a deficiency in the development of molecular diagnostic assays that ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll